Gastrointestinal Cancer News

Harboring a BRAF V600E mutation appeared associated with a poorer prognosis and greater risk for recurrence after curative-intent resection compared with KRAS mutations among patients with colorectal cancer and liver metastasis, according to study results.

Results of a recent study provided continued confirmation that increased rates of hepatocellular carcinoma among patients treated with direct-acting antivirals compared with interferon correlated with patient characteristics such as age and liver function rather than treatment.

Removing more lymph nodes during surgical resection could help improve survival rates among patients with right-sided colorectal cancer, according to research presented at the 2018 American College of Surgeons Quality and Safety Conference in Orlando.

Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for overall and certain site-specific cancers in women vs. men, according to findings from a meta-analysis published in Diabetologia.

Patients with advanced colon cancer who drank artificially sweetened soft drinks had a reduced risk for recurrence and cancer-specific mortality, study data showed.

Individuals who received monthly high concentrations of vitamin D without calcium did not appear to have lower risk for cancer, according to findings from a post-hoc analysis of the Vitamin D Assessment study.

The use of complementary medicine for the treatment of lung, breast, prostate or colorectal cancer appeared associated with refusal of conventional cancer treatment and almost double the risk for death compared with adherence to conventional cancer treatment, according to results of a retrospective, observational study.

Some patients with advanced pancreatic cancer who harbor BRCA1 or BRCA2 mutations derived clinical benefit from rucaparib, according to study results.

Liver cancer mortality increased from the ninth leading cause of cancer death in 2000 to sixth leading cause in 2016, according to a report published by the CDC.

Identifying certain compounds found in breath samples helped distinguish patients with pancreatic cancer from those without, according to research published in the British Journal of Surgery.